Unraveling stem cell and progenitor subsets in autologous grafts according to methods of mobilization: implications for prediction of hematopoietic recovery.

Autor: Roug AS; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark., Hokland LB; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark., Segel E; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark., Nielsen K; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark., Toft-Petersen M; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark., Van Kooten Niekerk PB; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark., Hokland P; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark., Nederby L; Aarhus University Hospital, Department of Hematology, Aarhus, Denmark. Electronic address: lnederby@ki.au.dk.
Jazyk: angličtina
Zdroj: Cytotherapy [Cytotherapy] 2014 Mar; Vol. 16 (3), pp. 392-401. Date of Electronic Publication: 2014 Jan 11.
DOI: 10.1016/j.jcyt.2013.11.006
Abstrakt: Background Aims: In the autologous setting, granulocyte colony-stimulating factor (G-CSF) (G), or, when failing, G plus plerixafor (G+P), are common regimens for mobilization of stem cells into peripheral blood. To delineate mobilization effects on graft composition and hematopoietic recovery, we compared contents of stem cells and progenitor cells in products of G+P- and G patients. Paired samples of G+P patients and prior insufficient G mobilization were available for analyses.
Methods: Subset analyses of grafts were performed by flow cytometry and myeloid colony-forming assay. In search of new markers to ascertain graft quality, we determined the fractions of aldehyde dehydrogenase bright (ALDH(br)) cells.
Results: G grafts contained higher percentages of CD34+ cells, CD34+CD38- cells, and committed progenitors (CD34+CD38+) compared with G+P grafts. A detailed characterization of the mobilized CD34+ cell subset showed higher percentages of CD38- among the CD34+ cells of the G+P group (P = 0.032). In contrast, the CD34+ cell subset in G grafts was characterized by a higher percentage of ALDH(br) cells (P < 0.0001). Studying engraftment and day +100 graft function the G and G+P transplanted patients were comparable with respect to neutrophils, whereas in platelets they differed. In the prediction of engraftment and hematopoietic recovery, the dose of infused ALDH(br) cells correlated best to both platelet (r = 0.565, P = 0.002) and neutrophil reconstitution (r = 0.366, P = 0.06).
Conclusions: Besides showing dissimilar distributions of CD34+CD38- cells and progenitors in G and G+P grafts, this study further designated ALDH(br) as a promising marker in determination and prediction of graft quality and hematopoietic recovery.
(Copyright © 2014 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: